Search results
Results from the WOW.Com Content Network
Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, is a pre-cancerous or non-invasive cancerous lesion of the breast. [ 1 ] [ 2 ] DCIS is classified as Stage 0. [ 3 ] It rarely produces symptoms or a breast lump that can be felt, typically being detected through screening mammography .
Ductal carcinoma in situ, or DCIS, accounts for up to 25% of diagnosed breast cancers and affects more than 50,000 women each year, according to the American Cancer Society.
Comedocarcinoma is a kind of breast cancer that demonstrates comedonecrosis, which is the central necrosis [1] of cancer cells within involved ducts. Comedocarcinomas are usually non-infiltrating and intraductal tumors, characterized as a comedo-type, high-grade ductal carcinoma in situ (DCIS).
Carcinoma in situ (CIS) is a group of abnormal cells. [ 1 ] [ 2 ] While they are a form of neoplasm , [ 3 ] there is disagreement over whether CIS should be classified as cancer . This controversy also depends on the exact CIS in question (e.g., cervical, skin, breast).
“I was recently diagnosed with DCIS, which stands for ductal carcinoma in situ, which is a form of breast cancer,” she said. “It is very, very, very early. It’s technically stage zero.
What is DCIS? According to the American Cancer Society, ductal carcinoma in situ (DCIS) is a non-invasive or pre-invasive type of breast cancer. It is also called intraductal carcinoma or stage 0 ...
PDCIS is managed primarily by surgical removal in the same manner as ductal carcinoma in situ tumors that have the same nuclear grade and estrogen receptor expression by their tumor cells (see treatment of ductal carcinoma in situ). [3] (Nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells ...
Ductal carcinoma in situ, a condition sometimes called non-invasive or stage-zero breast cancer, is a very early finding of disease in the cells that line the milk ducts of the breast.